{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T13:33:51Z","timestamp":1780925631838,"version":"3.54.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s11906-022-01189-2","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T04:32:33Z","timestamp":1648528353000},"page":"205-213","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Hypertensive Disorders of Pregnancy and Heart Failure Risk"],"prefix":"10.1007","volume":"24","author":[{"given":"Sarah A.","family":"Goldstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5004-8868","authenticated-orcid":false,"given":"Neha J.","family":"Pagidipati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,28]]},"reference":[{"key":"1189_CR1","doi-asserted-by":"crossref","unstructured":"\u2022 Cho L, Davis M, Elgendy I, Epps K, Lindley KJ, Mehta PK, et al. Summary of updated recommendations for primary prevention of cardiovascular disease in women: JACC State-of-the-Art Review. J Am College Cardiol. 2020;75:2602\u20132618. Comprehensive review of primary prevention in women, and sex-specific risk factors to incorporate into risk management.","DOI":"10.1016\/j.jacc.2020.03.060"},{"key":"1189_CR2","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1161\/01.CIR.0000039105.49749.6F","volume":"106","author":"DM Lloyd-Jones","year":"2002","unstructured":"Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D\u2019agostino RB, Kannel WB, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002;106:3068\u201372.","journal-title":"Circulation"},{"key":"1189_CR3","first-page":"e38","volume":"133","author":"D Mozaffarian","year":"2016","unstructured":"Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation. 2016;133:e38\u2013360.","journal-title":"Circulation"},{"key":"1189_CR4","doi-asserted-by":"crossref","unstructured":"\u2022 Honigberg MC, Riise HKR, Daltveit AK, Tell GS, Sulo G, Igland J, et al. Heart failure in women with hypertensive disorders of pregnancy: insights from the cardiovascular disease in Norway project. Hypertension. 2020;76:1506\u20131513. Demonstration of strong relationship between recurrent preeclampsia and heart failure.","DOI":"10.1161\/HYPERTENSIONAHA.120.15654"},{"key":"1189_CR5","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1001\/jamacardio.2019.1746","volume":"4","author":"EB Haug","year":"2019","unstructured":"Haug EB, Horn J, Markovitz AR, Fraser A, Klykken B, Dalen H, et al. Association of conventional cardiovascular risk factors with cardiovascular disease after hypertensive disorders of pregnancy: analysis of the Nord-Tr\u00f8ndelag health study. JAMA Cardiol. 2019;4:628\u201335.","journal-title":"JAMA Cardiol"},{"key":"1189_CR6","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.hlc.2019.09.011","volume":"29","author":"C Arnott","year":"2020","unstructured":"Arnott C, Patel S, Hyett J, Jennings G, Woodward M, Celermajer DS, et al. Women and cardiovascular disease: pregnancy, the forgotten risk factor. Heart Lung Circ. 2020;29:662\u20137.","journal-title":"Heart Lung Circ"},{"key":"1189_CR7","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.bpobgyn.2011.01.006","volume":"25","author":"JA Hutcheon","year":"2011","unstructured":"Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011;25:391\u2013403.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"1189_CR8","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1097\/01.AOG.0000437382.03963.88","volume":"122","author":"Hypertension in pregnancy","year":"2013","unstructured":"Hypertension in pregnancy. executive summary. Obstet Gynecol. 2013;122:1122\u201331.","journal-title":"Obstet Gynecol"},{"key":"1189_CR9","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 ACOG Practice Bulletin No. 222: Gestational hypertension and preeclampsia. Obstetrics and gynecology. 2020;135:e237. Definition and current statistics on HDP.","DOI":"10.1097\/AOG.0000000000003891"},{"key":"1189_CR10","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/S0140-6736(06)68397-9","volume":"367","author":"KS Khan","year":"2006","unstructured":"Khan KS, Wojdyla D, Say L, G\u00fclmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. The lancet. 2006;367:1066\u201374.","journal-title":"The lancet"},{"key":"1189_CR11","doi-asserted-by":"publisher","first-page":"7897189","DOI":"10.1155\/2018\/7897189","volume":"2018","author":"GK Singh","year":"2018","unstructured":"Singh GK, Siahpush M, Liu L, Allender M. Racial\/ethnic, nativity, and sociodemographic disparities in maternal hypertension in the United States, 2014\u20132015. Int J Hypertens. 2018;2018:7897189.","journal-title":"Int J Hypertens"},{"key":"1189_CR12","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1097\/AOG.0b013e3181a45b25","volume":"113","author":"EV Kuklina","year":"2009","unstructured":"Kuklina EV, Ayala C, Callaghan WM. Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol. 2009;113:1299\u2013306.","journal-title":"Obstet Gynecol"},{"key":"1189_CR13","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/AOG.0000000000002114","volume":"130","author":"AA Creanga","year":"2017","unstructured":"Creanga AA, Syverson C, Seed K, Callaghan WM. Pregnancy-related mortality in the United States, 2011\u20132013. Obstet Gynecol. 2017;130:366\u201373.","journal-title":"Obstet Gynecol"},{"key":"1189_CR14","doi-asserted-by":"crossref","unstructured":"\u2022 Hauspurg A, Ying W, Hubel CA, Michos ED and Ouyang P. Adverse pregnancy outcomes and future maternal cardiovascular disease. Clin Cardiol. 2018;41:239\u2013246. Important review of associations between HDP and future CVD.","DOI":"10.1002\/clc.22887"},{"key":"1189_CR15","doi-asserted-by":"crossref","unstructured":"Wu P, Haththotuwa R, Kwok CS, Babu A, Kotronias RA, Rushton Cman A, et al. Preeclamps, Zaia and future cardiovascular health: a systematic review and meta-analysis. Circulation: Cardiovas Qual Outcomes. 2017;10:e003497.","DOI":"10.1161\/CIRCOUTCOMES.116.003497"},{"key":"1189_CR16","doi-asserted-by":"publisher","first-page":"224","DOI":"10.7326\/M17-2740","volume":"169","author":"JJ Stuart","year":"2018","unstructured":"Stuart JJ, Tanz LJ, Missmer SA, Rimm EB, Spiegelman D, James-Todd TM, et al. Hypertensive disorders of pregnancy and maternal cardiovascular disease risk factor development: an observational cohort study. Ann Intern Med. 2018;169:224\u201332.","journal-title":"Ann Intern Med"},{"key":"1189_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cardfail.2020.12.020","volume":"27","author":"JE Briller","year":"2021","unstructured":"Briller JE, Mogos MF, Muchira JM, Piano MR. Pregnancy associated heart failure with preserved ejection fraction: risk factors and maternal morbidity. J Card Fail. 2021;27:143\u201352.","journal-title":"J Card Fail"},{"key":"1189_CR18","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/j.jacc.2013.08.717","volume":"62","author":"N Bello","year":"2013","unstructured":"Bello N, Rendon ISH, Arany Z. The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis. J Am Coll Cardiol. 2013;62:1715\u201323.","journal-title":"J Am Coll Cardiol"},{"key":"1189_CR19","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Brown HL, Warner JJ, Gianos E, Gulati M, Hill AJ, Hollier LM, et al. The American College of O and Gynecologists. Promoting risk identification and reduction of cardiovascular disease in women through collaboration with obstetricians and gynecologists: a presidential advisory from the american heart association and the American College of Obstetricians and Gynecologists. Circulation. 2018;137:e843-e852. Call-to-action for cardiologists, primary care clinicians, and obstetricians to collaborate in order to minimize future CVD risk in women.","DOI":"10.1161\/CIR.0000000000000582"},{"key":"1189_CR20","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/01.AOG.0000437382.03963.88","volume":"122","author":"Hypertension in pregnancy","year":"2013","unstructured":"Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122:1122\u201331.","journal-title":"Obstet Gynecol"},{"key":"1189_CR21","first-page":"228","volume":"17","author":"SA Isezuo","year":"2007","unstructured":"Isezuo SA, Abubakar SA. Epidemiologic profile of peripartum cardiomyopathy in a tertiary care hospital. Ethn Dis. 2007;17:228\u201333.","journal-title":"Ethn Dis"},{"key":"1189_CR22","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.4065\/80.12.1602","volume":"80","author":"JD Fett","year":"2005","unstructured":"Fett JD, Christie LG, Carraway RD, Murphy JG. Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc. 2005;80:1602\u20136.","journal-title":"Mayo Clin Proc"},{"key":"1189_CR23","doi-asserted-by":"crossref","unstructured":"Kolte D, Khera S, Aronow WS, Palaniswamy C, Mujib M, Ahn C, et al. Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study. J Am Heart Assoc. 2014;3:e001056.","DOI":"10.1161\/JAHA.114.001056"},{"key":"1189_CR24","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1097\/AOG.0b013e318229e6de","volume":"118","author":"EP Gunderson","year":"2011","unstructured":"Gunderson EP, Croen LA, Chiang V, Yoshida CK, Walton D, Go AS. Epidemiology of peripartum cardiomyopathy: incidence, predictors, and outcomes. Obstet Gynecol. 2011;118:583\u201391.","journal-title":"Obstet Gynecol"},{"key":"1189_CR25","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.amjcard.2007.02.092","volume":"100","author":"SS Brar","year":"2007","unstructured":"Brar SS, Khan SS, Sandhu GK, Jorgensen MB, Parikh N, Hsu JW, et al. Incidence, mortality, and racial differences in peripartum cardiomyopathy. Am J Cardiol. 2007;100:302\u20134.","journal-title":"Am J Cardiol"},{"key":"1189_CR26","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jacc.2009.09.043","volume":"55","author":"MB Gentry","year":"2010","unstructured":"Gentry MB, Dias JK, Luis A, Patel R, Thornton J, Reed GL, et al. African-American women have a higher risk for developing peripartum cardiomyopathy. J Am Coll Cardiol. 2010;55:654\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"1189_CR27","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1097\/AOG.0b013e31826e46a1","volume":"120","author":"MA Harper","year":"2012","unstructured":"Harper MA, Meyer RE, Berg CJ. Peripartum cardiomyopathy: population-based birth prevalence and 7-year mortality. Obstet Gynecol. 2012;120:1013\u20139.","journal-title":"Obstet Gynecol"},{"key":"1189_CR28","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jchf.2013.04.011","volume":"1","author":"DP Kao","year":"2013","unstructured":"Kao DP, Hsich E, Lindenfeld J. Characteristics, adverse events, and racial differences among delivering mothers with peripartum cardiomyopathy. JACC Heart Fail. 2013;1:409\u201316.","journal-title":"JACC Heart Fail"},{"key":"1189_CR29","doi-asserted-by":"crossref","unstructured":"Behrens I, Basit S, Lykke JA, Ranthe MF, Wohlfahrt J, Bundgaard H, et al. Hypertensive disorders of pregnancy and peripartum cardiomyopathy: a nationwide cohort study. PLoS One. 2019;14:e0211857.","DOI":"10.1371\/journal.pone.0211857"},{"key":"1189_CR30","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11040","volume":"485","author":"IS Patten","year":"2012","unstructured":"Patten IS, Rana S, Shahul S, Rowe GC, Jang C, Liu L, et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature. 2012;485:333\u20138.","journal-title":"Nature"},{"key":"1189_CR31","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jchf.2016.01.004","volume":"4","author":"J Damp","year":"2016","unstructured":"Damp J, Givertz MM, Semigran M, Alharethi R, Ewald G, Felker GM, et al. Relaxin-2 and soluble Flt1 levels in peripartum cardiomyopathy: results of the multicenter IPAC study. JACC Heart Fail. 2016;4:380\u20138.","journal-title":"JACC Heart Fail"},{"key":"1189_CR32","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jacc.2015.06.1309","volume":"66","author":"DM McNamara","year":"2015","unstructured":"McNamara DM, Elkayam U, Alharethi R, Damp J, Hsich E, Ewald G, et al. Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC study (investigations of pregnancy-associated cardiomyopathy). J Am Coll Cardiol. 2015;66:905\u201314.","journal-title":"J Am Coll Cardiol"},{"issue":"171","key":"1189_CR33","first-page":"e1","volume":"201","author":"KA Modi","year":"2009","unstructured":"Modi KA, Illum S, Jariatul K, Caldito G, Reddy PC. Poor outcome of indigent patients with peripartum cardiomyopathy in the United States. Am J Obstet Gynecol. 2009;201(171):e1-5.","journal-title":"Am J Obstet Gynecol"},{"key":"1189_CR34","doi-asserted-by":"crossref","unstructured":"Lindley KJ, Conner SN, Cahill AG, Novak E and Mann DL. Impact of preeclampsia on clinical and functional outcomes in women with peripartum cardiomyopathy. Circ Heart Fail. 2017;10.","DOI":"10.1161\/CIRCHEARTFAILURE.116.003797"},{"key":"1189_CR35","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ahj.2006.02.008","volume":"152","author":"AM Amos","year":"2006","unstructured":"Amos AM, Jaber WA, Russell SD. Improved outcomes in peripartum cardiomyopathy with contemporary. Am Heart J. 2006;152:509\u201313.","journal-title":"Am Heart J"},{"key":"1189_CR36","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.cardfail.2011.01.007","volume":"17","author":"S Goland","year":"2011","unstructured":"Goland S, Bitar F, Modi K, Safirstein J, Ro A, Mirocha J, et al. Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy. J Card Fail. 2011;17:426\u201330.","journal-title":"J Card Fail"},{"key":"1189_CR37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ijgo.2007.11.007","volume":"101","author":"N Duran","year":"2008","unstructured":"Duran N, G\u00fcnes H, Duran I, Biteker M, Ozkan M. Predictors of prognosis in patients with peripartum cardiomyopathy. Int J Gynaecol Obstet. 2008;101:137\u201340.","journal-title":"Int J Gynaecol Obstet"},{"key":"1189_CR38","doi-asserted-by":"crossref","unstructured":"Blauwet LA, Delgado-Montero A, Ryo K, Marek JJ, Alharethi R, Mather PJ, et al. 3rd. Right ventricular function in peripartum cardiomyopathy at presentation is associated with subsequent left ventricular recovery and clinical outcomes. Circ Heart Fail. 2016;9.","DOI":"10.1161\/CIRCHEARTFAILURE.115.002756"},{"key":"1189_CR39","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1055\/s-0038-1669439","volume":"36","author":"EM Davis","year":"2019","unstructured":"Davis EM, Ewald G, Givertz MM, Rajagopalan N, Cooper LT Jr, Briller J, et al. Maternal obesity affects cardiac remodeling and recovery in women with peripartum cardiomyopathy. Am J Perinatol. 2019;36:476\u201383.","journal-title":"Am J Perinatol"},{"key":"1189_CR40","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cardfail.2013.03.004","volume":"19","author":"S Goland","year":"2013","unstructured":"Goland S, Modi K, Hatamizadeh P, Elkayam U. Differences in clinical profile of African-American women with peripartum cardiomyopathy in the United States. J Card Fail. 2013;19:214\u20138.","journal-title":"J Card Fail"},{"key":"1189_CR41","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1161\/HYPERTENSIONAHA.118.11191","volume":"73","author":"B Thilaganathan","year":"2019","unstructured":"Thilaganathan B, Kalafat E. Cardiovascular system in preeclampsia and beyond. Hypertension. 2019;73:522\u201331.","journal-title":"Hypertension"},{"key":"1189_CR42","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1161\/CIRCULATIONAHA.113.003664","volume":"130","author":"K Melchiorre","year":"2014","unstructured":"Melchiorre K, Sharma R, Thilaganathan B. Cardiovascular implications in preeclampsia: an overview. Circulation. 2014;130:703\u201314.","journal-title":"Circulation"},{"key":"1189_CR43","doi-asserted-by":"crossref","unstructured":"Bartsch E, Medcalf KE, Park AL, Ray JG. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ (Clinical research ed). 2016;353:i1753.","DOI":"10.1136\/bmj.i1753"},{"key":"1189_CR44","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/j.1471-0528.2003.02069.x","volume":"110","author":"JE Ramsay","year":"2003","unstructured":"Ramsay JE, Stewart F, Greer IA, Sattar N. Microvascular dysfunction: a link between pre-eclampsia and maternal coronary heart disease. BJOG. 2003;110:1029\u201331.","journal-title":"BJOG"},{"key":"1189_CR45","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1161\/CIRCULATIONAHA.112.128751","volume":"127","author":"T M\u00e4nnist\u00f6","year":"2013","unstructured":"M\u00e4nnist\u00f6 T, Mendola P, V\u00e4\u00e4r\u00e4sm\u00e4ki M, J\u00e4rvelin MR, Hartikainen AL, Pouta A, et al. Elevated blood pressure in pregnancy and subsequent chronic disease risk. Circulation. 2013;127:681\u201390.","journal-title":"Circulation"},{"key":"1189_CR46","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1161\/HYPERTENSIONAHA.110.150078","volume":"56","author":"ML Mongraw-Chaffin","year":"2010","unstructured":"Mongraw-Chaffin ML, Cirillo PM, Cohn BA. Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension. 2010;56:166\u201371.","journal-title":"Hypertension"},{"key":"1189_CR47","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.jacc.2011.02.005","volume":"57","author":"L Mosca","year":"2011","unstructured":"Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women\u20132011 update: a guideline from the American Heart Association. J Am Coll Cardiol. 2011;57:1404\u201323.","journal-title":"J Am Coll Cardiol"},{"key":"1189_CR48","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1159\/000508036","volume":"145","author":"R Wu","year":"2020","unstructured":"Wu R, Wang T, Gu R, Xing D, Ye C, Chen Y, et al. Hypertensive disorders of pregnancy and risk of cardiovascular disease-related morbidity and mortality: a systematic review and meta-analysis. Cardiology. 2020;145:633\u201347.","journal-title":"Cardiology"},{"key":"1189_CR49","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/00001703-200312000-00002","volume":"15","author":"D Williams","year":"2003","unstructured":"Williams D. Pregnancy: a stress test for life. Curr Opin Obstet Gynecol. 2003;15:465\u201371.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"1189_CR50","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.110.156810","volume":"56","author":"JW Rich-Edwards","year":"2010","unstructured":"Rich-Edwards JW, McElrath TF, Karumanchi SA, Seely EW. Breathing life into the lifecourse approach: pregnancy history and cardiovascular disease in women. Hypertension. 2010;56:331\u20134.","journal-title":"Hypertension"},{"key":"1189_CR51","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1159\/000367627","volume":"51","author":"G Osol","year":"2014","unstructured":"Osol G, Bernstein I. Preeclampsia and maternal cardiovascular disease: consequence or predisposition? J Vasc Res. 2014;51:290\u2013304.","journal-title":"J Vasc Res"},{"key":"1189_CR52","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/ajum.12173","volume":"22","author":"AS Thayaparan","year":"2019","unstructured":"Thayaparan AS, Said JM, Lowe SA, McLean A, Yang Y. Pre-eclampsia and long-term cardiac dysfunction: a review of asymptomatic cardiac changes existing well beyond the post-partum period. Australas J Ultrasound Med. 2019;22:234\u201344.","journal-title":"Australas J Ultrasound Med"},{"key":"1189_CR53","doi-asserted-by":"publisher","first-page":"9795765","DOI":"10.1155\/2019\/9795765","volume":"2019","author":"E Timokhina","year":"2019","unstructured":"Timokhina E, Kuzmina T, Strizhakov A, Pitskhelauri E, Ignatko I, Belousova V. Maternal cardiac function after normal delivery, preeclampsia, and eclampsia: a prospective study. J Pregnancy. 2019;2019:9795765.","journal-title":"J Pregnancy"},{"key":"1189_CR54","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/uog.17343","volume":"49","author":"C Ghossein-Doha","year":"2017","unstructured":"Ghossein-Doha C, van Neer J, Wissink B, Breetveld NM, de Windt LJ, van Dijk AP, et al. Pre-eclampsia: an important risk factor for asymptomatic heart failure. Ultrasound Obstet Gynecol. 2017;49:143\u20139.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1189_CR55","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1161\/01.HYP.0000256565.20983.d4","volume":"49","author":"CA Hubel","year":"2007","unstructured":"Hubel CA, Wallukat G, Wolf M, Herse F, Rajakumar A, Roberts JM, et al. Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia. Hypertension. 2007;49:612\u20137.","journal-title":"Hypertension"},{"key":"1189_CR56","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-1-4939-7498-6_4","volume":"1710","author":"SR Hobson","year":"2018","unstructured":"Hobson SR, Lim R, Mockler JC, Gurusinghe S, Wallace EM. Role of activin A in the pathogenesis of endothelial cell dysfunction in preeclampsia. Methods Mol Biol. 2018;1710:39\u201352.","journal-title":"Methods Mol Biol"},{"key":"1189_CR57","doi-asserted-by":"crossref","unstructured":"Roh JD, Hobson R, Chaudhari V, Quintero P, Yeri A, Benson M, et al. Activin type II receptor signaling in cardiac aging and heart failure. Sci Transl Med. 2019;11.","DOI":"10.1126\/scitranslmed.aau8680"},{"key":"1189_CR58","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1161\/HYPERTENSIONAHA.118.10888","volume":"72","author":"S Shahul","year":"2018","unstructured":"Shahul S, Ramadan H, Nizamuddin J, Mueller A, Patel V, Dreixler J, et al. Activin A and late postpartum cardiac dysfunction among women with hypertensive disorders of pregnancy. Hypertension. 2018;72:188\u201393.","journal-title":"Hypertension"},{"key":"1189_CR59","doi-asserted-by":"crossref","unstructured":"deMartelly VA, Dreixler J, Tung A, Mueller A, Heimberger S, Fazal AA, et al. Long-term postpartum cardiac function and its association with preeclampsia. J Am Heart Assoc. 2021;10:e018526.","DOI":"10.1161\/JAHA.120.018526"},{"key":"1189_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10654-013-9762-6","volume":"28","author":"MC Brown","year":"2013","unstructured":"Brown MC, Best KE, Pearce MS, Waugh J, Robson SC, Bell R. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur J Epidemiol. 2013;28:1\u201319.","journal-title":"Eur J Epidemiol"},{"key":"1189_CR61","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1007\/s00125-016-4098-x","volume":"59","author":"P Wu","year":"2016","unstructured":"Wu P, Kwok CS, Haththotuwa R, Kotronias RA, Babu A, Fryer AA, et al. Pre-eclampsia is associated with a twofold increase in diabetes: a systematic review and meta-analysis. Diabetologia. 2016;59:2518\u201326.","journal-title":"Diabetologia"},{"key":"1189_CR62","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Honigberg MC, Zekavat SM, Aragam K, Klarin D, Bhatt DL, Scott NS, et al. Long-term cardiovascular risk in women with hypertension during pregnancy. J Am Coll Cardiol. 2019;74:2743\u20132754. Demonstration of the association between HDP and future CVD (including HF, CAD, aortic stenosis, and mitral regurgitation) using a large cohort from the UK Biobank.","DOI":"10.1016\/j.jacc.2019.09.052"},{"key":"1189_CR63","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1016\/j.jacc.2020.03.028","volume":"75","author":"VD Garovic","year":"2020","unstructured":"Garovic VD, White WM, Vaughan L, Saiki M, Parashuram S, Garcia-Valencia O, et al. Incidence and long-term outcomes of hypertensive disorders of pregnancy. J Am Coll Cardiol. 2020;75:2323\u201334.","journal-title":"J Am Coll Cardiol"},{"key":"1189_CR64","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1161\/HYPERTENSIONAHA.110.162321","volume":"57","author":"K Melchiorre","year":"2011","unstructured":"Melchiorre K, Sutherland GR, Baltabaeva A, Liberati M, Thilaganathan B. Maternal cardiac dysfunction and remodeling in women with preeclampsia at term. Hypertension. 2011;57:85\u201393.","journal-title":"Hypertension"},{"key":"1189_CR65","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1001\/jama.2021.14781","volume":"326","author":"KW Davidson","year":"2021","unstructured":"Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, et al. Aspirin use to prevent preeclampsia and related morbidity and mortality: US preventive services task force recommendation statement. JAMA. 2021;326:1186\u201391.","journal-title":"JAMA"},{"key":"1189_CR66","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/AOG.0000000000003567","volume":"135","author":"JI Rosenbloom","year":"2020","unstructured":"Rosenbloom JI, Lewkowitz AK, Lindley KJ, Nelson DM, Macones GA, Cahill AG, et al. Expectant management of hypertensive disorders of pregnancy and future cardiovascular morbidity. Obstet Gynecol. 2020;135:27\u201335.","journal-title":"Obstet Gynecol"},{"key":"1189_CR67","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.preghy.2020.05.015","volume":"21","author":"JI Rosenbloom","year":"2020","unstructured":"Rosenbloom JI, Stwalley D, Lindley KJ, Michael Nelson D, Olsen MA, Stout MJ. Latency of preterm hypertensive disorders of pregnancy and subsequent cardiovascular complications. Pregnancy hypertens. 2020;21:139\u201344.","journal-title":"Pregnancy hypertens"},{"key":"1189_CR68","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/0310057X9402200202","volume":"22","author":"HD Swan","year":"1994","unstructured":"Swan HD, Borshoff DC. Informed consent\u2013recall of risk information following epidural analgesia in labour. Anaesth intensive care. 1994;22:139\u201341.","journal-title":"Anaesth intensive care"},{"key":"1189_CR69","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3109\/10641955.2010.544955","volume":"31","author":"B Young","year":"2012","unstructured":"Young B, Hacker MR, Rana S. Physicians\u2019 knowledge of future vascular disease in women with preeclampsia. Hypertens pregnancy. 2012;31:50\u20138.","journal-title":"Hypertens pregnancy"},{"key":"1189_CR70","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1161\/HYPERTENSIONAHA.112.198812","volume":"60","author":"J Spaan","year":"2012","unstructured":"Spaan J, Peeters L, Spaanderman M, Brown M. Cardiovascular risk management after a hypertensive disorder of pregnancy. Hypertension. 2012;60:1368\u201373.","journal-title":"Hypertension"},{"key":"1189_CR71","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/clc.22896","volume":"41","author":"CD Brindis","year":"2018","unstructured":"Brindis CD, Freund KM. The ramifications of recent health policy actions for cardiovascular care of women: progress, threats, and opportunities. Clin Cardiol. 2018;41:173\u20138.","journal-title":"Clin Cardiol"},{"key":"1189_CR72","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1055\/s-0038-1669441","volume":"36","author":"GN Smith","year":"2019","unstructured":"Smith GN, Pudwell J, Saade GR. Impact of the New American Hypertension Guidelines on the prevalence of postpartum hypertension. Am J Perinatol. 2019;36:440\u20132.","journal-title":"Am J Perinatol"},{"key":"1189_CR73","doi-asserted-by":"crossref","unstructured":"Benschop L, Duvekot JJ, Versmissen J, van Broekhoven V, Steegers EAP and Roeters van Lennep JE. Blood pressure profile 1 year after severe preeclampsia. Hypertension. 2018;71:491\u2013498.","DOI":"10.1161\/HYPERTENSIONAHA.117.10338"},{"key":"1189_CR74","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/jp.2016.137","volume":"36","author":"LD Levine","year":"2016","unstructured":"Levine LD, Nkonde-Price C, Limaye M, Srinivas SK. Factors associated with postpartum follow-up and persistent hypertension among women with severe preeclampsia. J Perinatol. 2016;36:1079\u201382.","journal-title":"J Perinatol"},{"key":"1189_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preghy.2018.10.009","volume":"15","author":"A Hauspurg","year":"2019","unstructured":"Hauspurg A, Countouris ME, Jeyabalan A, Hubel CA, Roberts JM, Schwarz EB, et al. Risk of hypertension and abnormal biomarkers in the first year postpartum associated with hypertensive disorders of pregnancy among overweight and obese women. Pregnancy Hypertens. 2019;15:1\u20136.","journal-title":"Pregnancy Hypertens"},{"key":"1189_CR76","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1479-828X.2011.01345.x","volume":"51","author":"LK Callaway","year":"2011","unstructured":"Callaway LK, David McIntyre H, Williams GM, Najman JM, Lawlor DA, Mamun A. Diagnosis and treatment of hypertension 21 years after a hypertensive disorder of pregnancy. Aust N Z J Obstet Gynaecol. 2011;51:437\u201340.","journal-title":"Aust N Z J Obstet Gynaecol"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-022-01189-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11906-022-01189-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-022-01189-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T10:26:00Z","timestamp":1668248760000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11906-022-01189-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,28]]},"references-count":76,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["1189"],"URL":"https:\/\/doi.org\/10.1007\/s11906-022-01189-2","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,28]]},"assertion":[{"value":"14 March 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Sara A. Goldstein declares no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}